Nuklearmedizin 2011; 50(03): 21-22
DOI: 10.1055/s-0037-1621019
Case report
Schattauer GmbH

Follow-up of FDG-PET/CT findings in retroperitoneal fibrosis associated with abdominal aortic aneurysm

P. Wiggermann
1   Institut und Poliklinik für Diagnostische Radio logie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Germany
,
D. Aust
2   Institut für Pathologie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Germany
,
C. Stroszczynski
1   Institut und Poliklinik für Diagnostische Radio logie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Germany
,
J. Kotzerke
3   Klinik und Poliklinik für Nuklearmedizin, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Germany
,
K. Zöphel
1   Institut und Poliklinik für Diagnostische Radio logie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Germany
› Author Affiliations
Further Information

Publication History

received: 27 September 2010

accepted in revised form: 14 December 2010

Publication Date:
12 January 2018 (online)

 

 
  • References

  • 1 Amis Jr. ES. Retroperitoneal fibrosis. Am J Roentgenol 1991; 157: 321-329.
  • 2 De Prost N, Tucci MR, Melo MF. Assessment of lung inflammation with 18F-FDG PET during acute lung injury. Am J Roentgenol 2010; 195: 292-300.
  • 3 Gravius S, Gebhard M, Ackermann D. et al. Analysis of 18F-FDG uptake pattern in PET for diagnosis of aseptic loosening versus prosthesis infection after total knee arthroplasty. Nuklearmedizin 2010; 49: 115-123.
  • 4 Hayashida T, Sueyoshi E, Sakamoto I. et al. PET features of aortic diseases. Am J Roentgenol 2010; 195: 229-233.
  • 5 Jansen I, Hendriksz TR, Han SH. et al. 18F-fluoro - deoxyglucose position emission tomography (FDGPET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Eur J Intern Med 2010; 21: 216-221.
  • 6 Nakajo M, Jinnouchi S, Tanabe H, Tateno R. 18Ffluoro deoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis. J Comput Assist Tomogr 2007; 31: 539-543.
  • 7 Otsuka H, Morita N, Yamashita K, Nishitani H. FDGPET/CT findings of autoimmune pancreatitis associated with idiopathic retroperitoneal fibrosis. Ann Nucl Med 2007; 21: 593-596.
  • 8 Prager E, Wehrschuetz M, Bisail B. et al. Comparison of 18F-FDG and 67Ga-citrate in sarcoidosis imaging. Nuklearmedizin 2008; 47: 18-23.
  • 9 Vaglio A, Greco P, Versari A. et al. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent „scar"?. Clin Exp Rheumatol 2005; 23: 231-234.
  • 10 Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet 2006; 367: 241-251.
  • 11 Van Bommel EF, Siemes C, Hak LE. et al. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis 2007; 49: 615-625.
  • 12 Van Bommel EF, Jansen I, Hendriksz TR, Aarnoudse AL. Idiopathic retroperitoneal fibrosis. Medicine. Baltimore: 2009. 88 193-201.